Viscosupplementation Devices - Medical Devices Pipeline Product Landscape, 2021

The publisher's Medical Devices sector report, “Viscosupplementation Devices - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Viscosupplementation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Viscosupplementation is the process by which the synovial fluid at the joints is replaced by a Hyaluronate preparation which has viscous properties similar to the natural synovial fluid. Viscosupplementation is used for the treatment of osteoarthritis of knee and other joints.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Viscosupplementation Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Viscosupplementation Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Viscosupplementation Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Viscosupplementation Devices Overview

3 Products under Development

3.1 Viscosupplementation Devices - Pipeline Products by Stage of Development
3.2 Viscosupplementation Devices - Pipeline Products by Segment
3.3 Viscosupplementation Devices - Pipeline Products by Territory
3.4 Viscosupplementation Devices - Pipeline Products by Regulatory Path
3.5 Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
3.6 Viscosupplementation Devices - Ongoing Clinical Trials

4 Viscosupplementation Devices - Pipeline Products under Development by Companies

4.1 Viscosupplementation Companies - Pipeline Products by Stage of Development
4.2 Viscosupplementation Devices - Pipeline Products by Stage of Development

5 Viscosupplementation Companies and Product Overview

5.1 Ampio Pharmaceuticals Inc Company Overview
5.1.1 Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anika Therapeutics Inc Company Overview
5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Bone Therapeutics SA Company Overview
5.3.1 Bone Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Carticept Medical Inc Company Overview
5.4.1 Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Chi2Gel Ltd. Company Overview
5.5.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cocoon Biotech, Inc. Company Overview
5.6.1 Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Flex Biomedical Inc Company Overview
5.7.1 Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Herng Shan Co Ltd Company Overview
5.8.1 Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Kalvista Pharmaceuticals Inc Company Overview
5.9.1 Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 KiOmed Pharma Company Overview
5.10.1 KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview
5.11 Lineage Cell Therapeutics Inc Company Overview
5.11.1 Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Medytox Inc Company Overview
5.12.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Moebius Medical Ltd Company Overview
5.13.1 Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 Oligo Medic Inc Company Overview
5.14.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 OPKO Health Inc Company Overview
5.15.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Orchestra BioMed Inc Company Overview
5.16.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Prohibix LLC Company Overview
5.17.1 Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 Rottapharm Biotech Srl Company Overview
5.18.1 Rottapharm Biotech Srl Pipeline Products & Ongoing Clinical Trials Overview
5.19 Seikagaku Corp Company Overview
5.19.1 Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview
5.20 Shin Poong Pharm Co Ltd Company Overview
5.20.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Kansas Company Overview
5.21.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

6 Viscosupplementation- Recent Developments

6.1 Nov 09, 2021: Bioventus Reports Third Quarter Results Updates Full-Year 2021 Financial Guidance
6.2 Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
6.3 Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
6.4 Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
6.5 Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
6.6 Aug 10, 2021: Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
6.7 Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results
6.8 Jul 29, 2021: Bioventus Reports Preliminary Second Quarter Net Sales and Updates Full-Year 2021 Net Sales Guidance
6.9 Jul 29, 2021: Smith & Nephew announces Half-year Report
6.10 Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
6.11 Jul 14, 2021: Bioventus Appoints Mary Kay Ladone to Board of Directors
6.12 Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results
6.13 Jun 16, 2021: Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
6.14 May 17, 2021: Bioventus Senior Management to Present at Upcoming Investor Conferences
6.15 May 13, 2021: Anika to Host its 2021 Virtual Investor Day on June 3, 2021
6.16 May 12, 2021: Bioventus Reports First Quarter Results; Updates Full Year 2021 Financial Guidance
6.17 May 03, 2021: KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Paul K. Audhya, MD, MBA as Chief Medical Officer
6.18 Apr 05, 2021: Anika to Participate in the 20th Annual Needham Virtual Healthcare Conference
6.19 Mar 19, 2021: KalVista Pharmaceuticals appoints Nancy Stuart to Board of Directors
6.20 Mar 11, 2021: Anika to Participate in the Sidoti Spring Virtual Investor Conference
6.21 Mar 04, 2021: Larry Chen Joins Bioventus as Managing Director China and Asia Pacific
6.22 Mar 04, 2021: Anika Reports Fourth Quarter and Year-End 2020 Financial Results
6.23 Mar 01, 2021: Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
6.24 Feb 18, 2021: KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
6.25 Feb 18, 2021: Smith+Nephew Fourth Quarter and Full Year 2020 Results
6.26 Feb 18, 2021: D.C. CFO Jeffrey DeWitt to resign next month amid pandemic-tinged budget season
6.27 Jan 21, 2021: OrthogenRx announces 2020 achievements

7 Appendix

7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer

List of Tables

Viscosupplementation Devices - Pipeline Products by Stage of Development
Viscosupplementation Devices - Pipeline Products by Segment
Viscosupplementation Devices - Pipeline Products by Territory
Viscosupplementation Devices - Pipeline Products by Regulatory Path
Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
Viscosupplementation Devices - Ongoing Clinical Trials
Viscosupplementation Companies - Pipeline Products by Stage of Development
Viscosupplementation Devices - Pipeline Products by Stage of Development
Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Ampion - Product Status
Ampion - Product Description
Ampion - Hand Osteoarthritis - Product Status
Ampion - Hand Osteoarthritis - Product Description
Ampio Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Ampion - A Randomized, Controlled, Double-blind Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of Ampion in Adults with Pain Due to Severe Osteoarthritis of the Knee
Ampion - A Randomized, Double-blinded, Placebo Controlled Phase II Study to Evaluate the Safety and Efficacy of IV Ampion in Adult COVID-19 Patients Requiring Oxygen Supplementation
Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Cingal - Product Status
Cingal - Product Description
Hyaluronic Acid - Synovial Joints - Product Status
Hyaluronic Acid - Synovial Joints - Product Description
MONOVISC - Hip - Product Status
MONOVISC - Hip - Product Description
ORTHOVISC-T - Product Status
ORTHOVISC-T - Product Description
Sodium Hyaluronate - Osteoarthritis - Product Status
Sodium Hyaluronate - Osteoarthritis - Product Description
Anika Therapeutics Inc - Ongoing Clinical Trials Overview
Cingal - A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis (ECHO Study)
Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Ankle Joint
Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Hip Joint
Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Shoulder Joint
Bone Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
JTA-004 - Product Status
JTA-004 - Product Description
Bone Therapeutics SA - Ongoing Clinical Trials Overview
JTA-004 - A Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Agilus - Product Status
Agilus - Product Description
Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Chi2Knee - Product Status
Chi2Knee - Product Description
Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Silk Hydrogel - Product Status
Silk Hydrogel - Product Description
Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Flex Polymer - Product Status
Flex Polymer - Product Description
Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Hyalease 16 and 20 - Product Status
Hyalease 16 and 20 - Product Description
Hyalease 8 - Product Status
Hyalease 8 - Product Description
Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
ActaVisc - Product Status
ActaVisc - Product Description
Hydros - Product Status
Hydros - Product Description
Hydros TA - Product Status
Hydros TA - Product Description
Hydros TA - Hip - Product Status
Hydros TA - Hip - Product Description
KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview
Arthrovisc - Product Status
Arthrovisc - Product Description
Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
ReGlyde - Product Status
ReGlyde - Product Description
Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
MT941 - Product Status
MT941 - Product Description
Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
MM-II - Product Status
MM-II - Product Description
Moebius Medical Ltd - Ongoing Clinical Trials Overview
MM-II - A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Single-administration, Multiple-Dose Study to Demonstrate the Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects with Symptomatic Knee Osteoarthritis
Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
JointVisc - Product Status
JointVisc - Product Description
OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Enko 1 - Product Status
Enko 1 - Product Description
Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
SirolimusEFR Intra-Articular Injection - Product Status
SirolimusEFR Intra-Articular Injection - Product Description
Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview
Hyalease Hydrogel Microparticle - Product Status
Hyalease Hydrogel Microparticle - Product Description
Rottapharm Biotech Srl Pipeline Products & Ongoing Clinical Trials Overview
PVA Hydrogel - Product Status
PVA Hydrogel - Product Description
Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview
JOYCLU 30mg Intra-Articular Injection - Product Status
JOYCLU 30mg Intra-Articular Injection - Product Description
SI-613 - Enthesopathy - Product Status
SI-613 - Enthesopathy - Product Description
Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
HyalOne - Product Status
HyalOne - Product Description
University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
3-D Colloidal Gel - Product Status
3-D Colloidal Gel - Product Description
Glossary

List of Figures

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Ampio Pharmaceuticals Inc
Anika Therapeutics Inc
Bone Therapeutics SA
Carticept Medical Inc
Chi2Gel Ltd.
Cocoon Biotech, Inc.
Flex Biomedical Inc
Herng Shan Co Ltd
Kalvista Pharmaceuticals Inc
KiOmed Pharma
Lineage Cell Therapeutics Inc
Medytox Inc
Moebius Medical Ltd
Oligo Medic Inc
OPKO Health Inc
Orchestra BioMed Inc
Prohibix LLC
Rottapharm Biotech Srl
Seikagaku Corp
Shin Poong Pharm Co Ltd
University of Kansas

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3899EUR$4,000USD£3,248GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7798EUR$8,000USD£6,497GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€11697EUR$12,000USD£9,745GBP

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033

Hyaluronic Acid Viscosupplementation - Market Insights, Competitive Landscape, and Market Forecast - 2030

Viscosupplementation Market by Product, Source, Application, End-use - Global Forecast 2025-2030

Viscosupplementation Global Market Report 2024

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030